Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3P Biopharmaceuticals is a leading European Contract Development and Manufacturing Organization (CDMO) specializing in the process development and GMP manufacturing of biologics and advanced therapy medicinal products (ATMPs). The company provides end-to-end services ranging from initial cell line development and process optimization to large-scale clinical and commercial production. With expertise in mammalian, microbial, and yeast expression systems, 3P supports a diverse global clientele in the pharmaceutical and biotechnology sectors. Operating out of state-of-the-art facilities in Spain, the company is recognized for its high regulatory standards and its ability to handle complex protein and cell-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3P Pharmaceuticals.